跳至主要内容
临床试验/NCT02965612
NCT02965612Unknown不适用

Tolerability and Side Effects for a New Device in Specific Immunotherapy for Allergic Child

Mariella Enoc1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2015年5月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
36
试验地点
1
主要终点
prevalence of pain

研究概览

简要总结

The recent interest that the Specific Immunotherapy (ITS) has aroused is due to the positive potential role that could be played, in particular in the forms of allergic asthma, because this method constitute the only intervention (unlike that pharmacologic) able to act on the same causes of the disease, altering the natural history. To achieve this the investigator has tried to use the specific subcutaneous immunotherapy (SCIT), to which there are studies that, with scientific rigor, have demonstrated the benefits.

详细描述

The Investigator proposes to compare, in children with allergic rhinitis and / or allergic asthma to grasses, the pain caused by the administration of the Specific Immunotherapy (ITS) via epicutaneous with autoinjector (INJEX) pressure without needle vs. the traditional subcutaneous immunotherapy (SCIT).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
5 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Written informed consent from both parents / legal guardian;
  • Of both sexes;
  • Between the ages of 5 to 18 sensitized to grasses Awareness for grasses will be established with prick test;
  • Rhinitis established according to the ARIA (Allergic Rhinitis and its Impact on Asthma) guidelines and / or stage 1 or 2 Asthma according to GINA classification (Global Initiative for Asthma)
  • It may, or not, be going on ITS with s.c. administration

排除标准

  • Children under age 5 and age> 18 years;
  • Autoimmune diseases and immunodeficiencies;
  • Neoplasms;
  • Severe psychological problems;
  • Treatment with β-blockers;
  • Poor compliance, including language training;
  • Severe asthma uncontrolled by medication or irreversible airway obstruction (FEV1 less than 70% of the predicted value);
  • Severe cardiovascular diseases in which may be hazardous in the administration of adrenaline

结局指标

主要结局

prevalence of pain

时间窗: monthly for 6 month

questionnaire of the pain scale monthly at each seat vaccination soon after every administration : the Wong-Baker scale for children aged 3 to 8 years and the classical analogue scale from 8 years and 1 day to 18 years.

次要结局

  • Incidence of procedure adverse events(6 month)
  • prevalence of pain(20 minutes after every administration)

研究者

发起方
Mariella Enoc
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Mariella Enoc

President

Bambino Gesù Hospital and Research Institute

研究点 (1)

Loading locations...

相似试验